AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. WINT
  4. [8-K] Windtree Therapeutics, Inc. Reports Material Event

[8-K] Windtree Therapeutics, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source:

Stock WINT logo
Windtree Therapeutics Inc

NASDAQ:WINT

WINT Rankings

#11399 Ranked by Market Cap
N/A Ranked by Dividends
#24 Top Gainer

WINT Latest News

Jul 16, 2025
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60聽Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
Jul 2, 2025
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
Jun 30, 2025
Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis
Jun 26, 2025
Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem鈥檚 Hormone-Free, On-Demand Prescription Contraceptive Gel
Jun 16, 2025
Windtree Announces Publication of Istaroxime聽Positive Phase 2 SEISMiC B Study

WINT Latest SEC Filings

Jul 14, 2025
[EFFECT] Windtree Therapeutics, Inc. SEC Filing
Jul 10, 2025
[S-1/A] Windtree Therapeutics, Inc. Amends IPO Registration Statement
Jul 7, 2025
[S-1/A] Windtree Therapeutics, Inc. Amends IPO Registration Statement
Jul 3, 2025
[8-K] Windtree Therapeutics, Inc. Reports Material Event
Jun 27, 2025
[8-K] Windtree Therapeutics, Inc. Reports Material Event

WINT Stock Data

6.24M
3.66M
0.07%
1.77%
11.08%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WARRINGTON